Insider Trading - Candel Therapeutics Inc. (CADL)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-07-27 Purchase | 2021-07-29 9:02 pm | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 56,000 | $7.3353 | $410,778 | 56,000 (Direct) | View |
| 2021-07-29 Purchase | 2021-08-02 8:02 pm | Candel Therapeutics Inc. | CADL | Caffo Nathan Chief Business Officer | 6,000 | $8 | $48,000 | 6,000 (Direct) | View |
| 2021-07-29 Purchase | 2021-08-02 8:06 pm | Candel Therapeutics Inc. | CADL | Canepa John J CFO | 10,125 | $8 | $81,000 | 10,125 (Direct) | View |
| 2021-07-29 Purchase | 2021-08-02 8:09 pm | Candel Therapeutics Inc. | CADL | Tak Paul Peter CEO | 25,000 | $8 | $200,000 | 25,000 (Direct) | View |
| 2021-07-29 Purchase | 2021-08-02 8:11 pm | Candel Therapeutics Inc. | CADL | Nguyen Diem Director | 10,000 | $8 | $80,000 | 10,000 (Direct) | View |
| 2021-07-29 Purchase | 2021-08-02 8:12 pm | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 125,000 | $8 | $1,000,000 | 125,000 (Indirect) | View |
| 2021-07-29 Purchase(A) | 2021-08-04 4:41 pm | Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner | 1,625,000 | $8 | $13,000,000 | 1,681,000 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-07-29 Conversion | 2021-08-02 8:04 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar Laura K. Chief Medical Officer | 56,096 | $0 | 931,039 (Direct) | View |
| 2021-07-29 Conversion | 2021-08-02 8:04 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar Laura K. Chief Medical Officer | 137,881 | $0 | 0 (Direct) | View |
| 2021-07-29 Conversion | 2021-08-02 8:08 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 679,158 | $0 | 679,158 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-02 8:08 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 553,752 | $0 | 553,752 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-02 8:08 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 1,669,303 | $0 | 0 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-02 8:08 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director | 1,361,069 | $0 | 0 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-02 8:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer | 162,137 | $0 | 1,015,923 (Direct) | View |
| 2021-07-29 Conversion | 2021-08-02 8:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Aguilar-Cordova Estuardo Chief Scientific Officer | 398,519 | $0 | 0 (Direct) | View |
| 2021-07-29 Conversion | 2021-08-02 8:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 283,514 | $0 | 283,514 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-02 8:12 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Martell Christopher Director | 696,851 | $0 | 0 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-04 4:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner | 679,158 | $0 | 679,158 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-04 4:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner | 553,752 | $0 | 553,752 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-04 4:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner | 1,669,303 | $0 | 0 (Indirect) | View |
| 2021-07-29 Conversion | 2021-08-04 4:41 pm | N/A N/A | Candel Therapeutics Inc. | CADL | Manning Paul B Director 10% Owner | 1,361,069 | $0 | 0 (Indirect) | View |